EPISODE · Mar 18, 2025 · 8 MIN
Why Millions of Americans are Taking GLP-1 Drugs like Wegovy, Ozempic, and Zepbound
from GLP-1 Tribe · host Eric Eden
We introduce our podcast at GLP-1 Tribe with an overview of everything people considering taking GLP-1 medications need to know. And why are millions of Americans taking these medicines? GLP-1 receptor agonists, a class of medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), explaining their mechanisms of action, approved uses for type 2 diabetes and weight management, and their history and development. They discuss the increasing prevalence of their use, typical effectiveness in clinical trials for blood sugar control and weight loss, common and serious side effects and risks, and findings from long-term studies. The sources also compare these medications, address cost and insurance coverage, and emphasize the importance of informed decision-making in consultation with healthcare providers regarding their use. Learn more about GLP-1 at the patient led community GLP1 Tribe https://glp1tribe.com/
Embed this episode
What this episode covers
We introduce our podcast at GLP-1 Tribe with an overview of everything people considering taking GLP-1 medications need to know. And why are millions of Americans taking these medicines? GLP-1 receptor agonists, a class of medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), explaining their mechanisms of action, approved uses for type 2 diabetes and weight management, and their history and development. They discuss the increasing prevalence of...
Ready to play
Why Millions of Americans are Taking GLP-1 Drugs like Wegovy, Ozempic, and Zepbound
No transcript for this episode yet
Similar Episodes
No similar episodes found.